ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

Please provide your email address to receive an email when new articles are posted on . A limited understanding of non-European DNA may hinder genetic testing interpretations, leading to disparities ...

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study. Certain common genetic changes might make some people with ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, said Wednesday it is launching a new program intended to increase access to exome sequencing for pediatric epilepsy patients.

The steps involved in evaluating and diagnosing patients with epilepsy are complicated. In a new and extensive literature review of available information, experts provide insights on the valuable role ...

Epilepsy is one of the most common neurological conditions in the world, yet myths and misconceptions continue to surround it. In many societies, seizures are still wrongly linked to superstition or ...